(82 days)
Not Found
No
The description focuses on standard oscillometric blood pressure measurement and data download for physician analysis, with no mention of AI/ML algorithms for data processing or interpretation.
No
The device is a monitor designed to measure and record vital signs, not to treat a condition or disease.
Yes
The device is designed to measure blood pressure and pulse rate, and the captured data is downloaded to a computer for analysis and interpretation by a physician. This process of collecting and analyzing physiological data to inform medical decisions aligns with the function of a diagnostic device.
No
The device description explicitly states it is a "compact, lightweight, non-invasive ambulatory blood monitoring system" that uses a "cuffed arm" and "automatically captured" measurements, indicating it includes hardware components for measurement and data capture.
Based on the provided information, the Ambulo 2400 Ambulatory Blood Pressure Monitor is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Ambulo 2400 Function: The Ambulo 2400 measures blood pressure and pulse rate directly from the patient's arm using a cuff and the oscillometric method. This is a non-invasive measurement taken in vivo (within the living body), not in vitro (in a test tube or laboratory setting).
- Lack of Sample Analysis: The device does not analyze biological samples. It measures physical parameters (pressure and pulse) directly from the patient.
Therefore, the Ambulo 2400 falls under the category of a non-invasive medical device for physiological monitoring, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The Ambulo 2400 Ambulatory Blood Pressure Monitor is designed to measure systolic and diastolic blood pressure and pulse rate of adults who are eighteen (18) years and older, using the oscillometric method on a cuffed arm.
Product codes (comma separated list FDA assigned to the subject device)
DXN
Device Description
The Ambulo 2400 is a compact, lightweight, non-invasive ambulatory blood monitoring system. The Ambulo 2400 can measure systolic and diastolic blood pressure, mean arterial pressure and pulse rate over a 24 hour period. It is easily configured and individually-fitted for each patient by a physician or health care professional. Measurements are automatically captured, without medical supervision, by the Ambulo 2400 and later downloaded to a computer for analysis and interpretation by a physician.
Since blood pressure naturally fluctuates throughout a full day according to various factors, such as sleep patterns, medication, diet, exercise and stress, a single measurement is not sufficient to make a sound diagnosis. Analyzing a person's blood pressure over an extended period of time can improve the diagnosis and ultimately the treatment. The Ambulo 2400 can collect blood pressure data under a variety of daily activities over a 24 hour period and then downloaded to a computer for analysis and treatment. The Ambulo 2400 may also be use on an ongoing basis to evaluate the effectiveness of a prescribed treatment.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
cuffed arm
Indicated Patient Age Range
eighteen (18) years and older
Intended User / Care Setting
physician or health care professional
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 870.1130 Noninvasive blood pressure measurement system.
(a)
Identification. A noninvasive blood pressure measurement system is a device that provides a signal from which systolic, diastolic, mean, or any combination of the three pressures can be derived through the use of tranducers placed on the surface of the body.(b)
Classification. Class II (performance standards).
0
510(k) Summary of Safety and Effectiveness
APR 2 3
Submitter Information:
Tiba Medical, Inc. 2701 NW Vaughn St., Suite 470 Portland, Oregon 97210 USA
Phone: 503-222-1500 FAX: 800-985-8422 www.tibamedical.com
USA Contact:
Merat Bagha, President
E-Mail: merat@tibamedical.com Phone: 503-222-1500 FAX: 800-985-8422 www.tibamedical.com
Device Name:
Trade Name: Ambulo 2400 Ambulatory Blood Pressure Monitoring System
Common Name: Ambulatory Blood Pressure Monitoring System Classification Name: System, Measurement, Blood-Pressure, Non-Invasive
Classification Product code: DXN
Predicate Device(s):
The Ambulo 2400 is substantially equivalent to the A&D Medical model TM-2430 Ambulatory Blood Pressure Monitoring system cleared for marker under K992808.
Device Description:
The Ambulo 2400 is a compact, lightweight, non-invasive ambulatory blood monitoring system. The Ambulo 2400 can measure systolic and diastolic blood pressure, mean arterial pressure and pulse rate over a 24 hour period. It is easily configured and individually-fitted for each patient by a physician or health care professional. Measurements are automatically captured, without medical supervision, by the Ambulo 2400 and later downloaded to a computer for analysis and interpretation by a physician.
Since blood pressure naturally fluctuates throughout a full day according to various factors, such as sleep patterns, medication, diet, exercise and stress, a single measurement is not sufficient to make a sound diagnosis. Analyzing a person's blood pressure over an extended period of time can improve the diagnosis and ultimately the treatment. The Ambulo 2400 can collect blood pressure data under a variety of daily activities over a 24 hour period and then downloaded to a computer for analysis and treatment. The Ambulo 2400 may also be use on an ongoing basis to evaluate the effectiveness of a prescribed treatment.
Page 1 of 3
1
Intended Use:
The Ambulo 2400 Ambulatory Blood Pressure Monitor is designed to measure systolic and diastolic blood pressure and pulse rate of adults who are eighteen (18) years and older, using the oscillometric method on a cuffed arm.
Technology Characteristics:
The Ambulo 2400 Ambulatory Blood Pressure Monitor is a batterypowered electromechanical device that utilizes a microcontroller along with air micropump and release valves to pump up and measure and store blood pressure and pulse rate via a standard cuff and using an oscillometric algorithm. The device is compact and lightweight, intended for everyday use by subjects (typically over a 24-hour period) to determine fluctuations in blood pressure during day and night. The device interfaces to a computer for configuration and download of measurements. The device has an LCD for displaying time of day, current status, measurement results, and/or any error conditions. The device also has a single button that allows the subject to initiate or stop a measurement, and to toggle the device between automatic measurement or PAUSE modes. The device is packaged with accessories including multiple cuffs, a carrying pouch, shoulder strap, application software, and a USB communication cable.
| Standard | Title and Comments |
|---|---|
| EN/IEC60601-1 | EN/IEC 60601 Medical Electrical Equipment - Part 1 General |
| Requirements for Safety, 1988: Amendment 1, 1991, Amendment | |
| 2, 1995 Note: EN/IEC60601-1, UL2601-1, and CSA, No. 22.2 | |
| #601.1 M90 cover the same electrical safety requirements | |
| EN/IEC60601-1-2:2001 | EN/IEC 60601-1-2:2001 Medical Electrical Equipment - Collateral |
| Standard; General Requirements for Safety: Electromagnetic | |
| Compatibility - Requirements and Test. | |
| EN/IEC60601-1-4:1996 | EN/IEC 60601-1-4:1996 Medical Electrical Equipment, - Collateral |
| Standard - General Requirements for programmable electrical | |
| EN/IEC 60601-1-6:2004 | EN/IEC 60601-1-6:2004 Medical Electrical - Collateral standard; |
| Usability | |
| EN/IEC 60601-2-30:2000 | EN/IEC 60601-2-30:2000 Medical Electrical Equipment - Part 2- |
| 30: Particular requirements for the safety including essential | |
| performance of automated cycling NIBP monitoring equipment |
Summary of Performance Testing:
2
ﮐﯿﺴ
| Standard | Title and Comments |
|---|---|
| AAMI/ANSI SP10;2002 | AAMI/ANSI SP10;2002 manual, electronic or automated |
| sphygmomanometers | |
| EU 2002/95/EC | RoHS-compliance (Pb-free components and solder; mercury-free |
| measurement device). | |
| MIL - STD 810E, 1989 | Temperature, Humidity, Altitude, Shock and Vibration |
| IEC 68-2-29 | Operating Mechanical Bump Test |
| EN IEC 60601-1:2000 | Operating Shock |
| ISTA Series 2 AB | Packaging Vibration |
Conclusion:
The Ambulo 2400 Ambulatory Blood Pressure Monitoring System is as safe and effective as the predicate device when used according to the instructions in the User's Guide supplied with the device.
Page 3 of 3
. .
3
Public Health Service
Image /page/3/Picture/2 description: The image shows the seal for the Department of Health & Human Services - USA. The seal is circular with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. In the center of the seal is a stylized caduceus, a symbol often associated with medicine and healthcare.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
APR 2 3 2008
Tiba Medical, Inc. c/o Mr. Merat Bagha President 2701 NW Vaughn St., Suite 470 Portland, OR 97201
Re: K080274
Trade/Device Name: Ambulo™ 2400 Regulation Number: 21 CFR 870.1130 Regulation Name: Noninvasive Blood Pressure Monitoring System Regulatory Class: Class II (two) Product Code: DXN Dated: January 30, 2008 Received: February 1, 2008
Dear Mr. Bagha:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
4
Page 2 – Mr. Merat Bagha
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at 240-276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Survoillance Systems at 240-276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
B. Zimmerman for
Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
INDICATIONS FOR USE
510(k) Number: __ K080274
Device Name:
Ambulo 2400 Ambulatory Blood Pressure Monitoring System
Indication for use:
The Ambulo 2400 Ambulatory Blood Pressure Monitor is designed to measure systolic and diastolic blood pressure and pulse rate of adults who are eighteen (18) years and older, using the oscillometric method on a cuffed arm.
Prescription Use X (Per 21 CFR 801.109)
OR Over-The-Counter_
(Please do not write below this line - continue on another page if needed)
Concurrence of CDRH, Office of Device Evaluation (ODE)
B. Bimmolmo
Vision Sian-O Division of Cardiovascular Devices, 510/ki Numb
Page 1 of 1
Contains Proprietary Information
Page 35 of 648